Abound Financial’s Merck MRK Stock Holding History

Abound Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.6K	Hold	246	–	–	0.01%	148
2025 Q4	$25.9K	Buy	+246	New	+$23.1K	0.01%	156
2025 Q2	–	Sell	-246	Closed	-$22.1K	–	188
2025 Q1	$22.1K	Buy	+246	New	+$23K	0.01%	161

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abound Financial's MRK Position: Q1 2026 in Review

Abound Financial held its Merck (MRK) position steady in Q1 2026 at 246 shares worth $29.6K. The position accounts for 0.01% of the portfolio, ranked #148.

Abound Financial first reported a position in MRK in Q1 2025 and has held it in 3 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Abound Financial held 246 shares of Merck worth $29.6K as of Q1 2026.
Abound Financial left its Merck share count unchanged in Q1 2026.
Merck made up 0.01% of Abound Financial's portfolio in Q1 2026, its #148 holding.
Abound Financial first reported a position in Merck in Q1 2025 and has held it in 3 quarters since.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Abound Financial's 13F filing for Q1 2026, filed 4 May 2026.